BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2011
View Archived Issues
MK-2206 advances to phase II testing in breast cancer
Read More
Phase II YF-476 trial begins recruitment of patients with Zollinger-Ellison syndrome
Read More
New PTEN/TP53/RB1 triple knockout model described of high-grade astrocytoma
Read More
Liver-selective glucokinase activator PFE-GKA-2 shows improved hypoglycemic control in vivo
Read More
RRx-001 to enter clinic as chemotherapeutic/radiosensitizer for cancer
Read More
Navitoclax enhances efficacy of taxanes in models of NSCLC
Read More
Vaccine based on rare adenoviral vectors is immunogenic in patients with HCV infection
Read More
Stealth Peptides presents phase I data on Bendavia
Read More
Probiodrug presents new glutaminyl cyclase inhibitors
Read More
Artemisinin is beneficial in patients with schizophrenia with elevated antibodies against T. gondii
Read More
Novel diacylglycerol O-acyltransferase 1 inhibitors reported
Read More
New androgen receptor ligands described by Bayer Schering Pharma
Read More
New compounds for treatment of HCV infection designed
Read More
FDA approves once-daily Viramune XR for use in combination for HIV-1 infection
Read More
United Paragon Associates patents new tachykinin NK2 receptor antagonists
Read More
OncoSec Medical and Inovio enter agreement for electroporation technology for cancer
Read More
Phase II PX-866 trial in glioblastoma begins enrollment
Read More
Quantum Genomics reports promising preclinical data on QGC-001
Read More
Merck & Co. acquires Inspire Pharma and expands ophthalmic pipeline
Read More
MedImmune enters strategic collaboration with Inserm Transfert
Read More
Progen Pharma completes enrollment in phase I trial of PG-11047
Read More
Favorable phase IIa data on NBI-98854 in patients with schizophrenia and tardive dyskinesia
Read More
Aragen Bioscience receives NIAID subcontracts to develop mAbs for infectious diseases
Read More
DARA BioSciences commences phase Ib study of DB-959
Read More
Enrollment completed in phase III trial of BEMA Buprenorphine for chronic pain
Read More
Celgene and ProMetic Life Sciences enter agreement for protein technologies
Read More